Distinctly DSP badge

Dedicated experts. Straightforward pricing. Perfect partnership.

DSP is regarded as the expert CRO in women’s health and reproductive endocrinology/infertility, having conducted 80% of all infertility studies in the United States over the past 18 years.

We’ve been named one of the fastest growing women-owned, women-led businesses in North America, and we continue to focus on what is most important to us: the needs of small to midsize pharmaceutical companies who too often get overcharged and underserviced.

If we sound like the right fit, let’s talk about how we can work together.

About Us

DSP takes a proactive, meticulous approach to customer studies and services. We understand customer needs and won’t settle for anything less than precision and accuracy for your clinical trial.

We provide an effortless contracting process with fixed pricing, integrated budgeting and no long-term contracts to simplify service delivery and minimize overhead.

Comprehensive clinical trial services ranging from study startup through FDA submission.

Therapeutic Experience

Over the years, we have managed and/or monitored more than 200 Phase I – IV clinical trials in various therapeutic areas, and have filed 26 New Drug Applications (NDA).

Although we take the utmost pride in advancing women’s health and reproductive endocrinology/infertility studies, DSP has also conducted extensive work in the following therapeutic areas:

Reproductive Endocrinology/Infertility

Women’s Health

Male Infertility

Urology

Gastrointestinal

Pain (Device and Drug)

Central Nervous System

Dermatology

Device (Human and Lab)

Endocrinology

Oncology

Pediatrics

Phase I (Healthy and Target Population)

WBENC Women’s Business Enterprise (WBE) Certification
Top 50 Fastest-Growing Women-Owned Companies in North America
Inc. 500 Fastest Growing Privately Held Companies
Inc. 5000 Fastest Growing Privately Held Companies

Request a call back.

Would you like to speak to us over the phone? Just submit your details and we’ll be in touch shortly.

    I would like to discuss:*